Precision BioSciences
DTIL
118 hedge funds and large institutions have $231M invested in Precision BioSciences in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, 42 increasing their positions, 34 reducing their positions, and 16 closing their positions.
48% more capital invested
Capital invested by funds: $156M → $231M (+$74.4M)
24% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 34
13% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 16
2% more funds holding
Funds holding: 116 → 118 (+2)
0.14% more ownership
Funds ownership: 1.63% → 1.76% (+0.14%)
4% less call options, than puts
Call options by funds: $1.39M | Put options by funds: $1.44M
33% less funds holding in top 10
Funds holding in top 10: 3 → 2 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$14.8M |
| 2 |
Citadel Advisors
Miami,
Florida
|
+$11.8M |
| 3 |
Millennium Management
New York
|
+$3.57M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
| 5 |
BlackRock
New York
|
+$2.19M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VP
venBio Partners
San Francisco,
California
|
-$8M |
| 2 |
Two Sigma Advisers
New York
|
-$1.61M |
| 3 |
Point72 Asset Management
Stamford,
Connecticut
|
-$1.57M |
| 4 |
CA
CHI Advisors
New York
|
-$1.33M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
-$1.31M |
DTIL Hedge Fund Activity: Q4 2020 in Review
118 of the 5,652 institutional investors tracked by Wall St. Rank reported a position in Precision BioSciences (DTIL) for Q4 2020, worth a combined $231M — up 48% from $156M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new DTIL positions and 16 closed out — a net gain of 2 holders — while 42 added to existing stakes and 34 trimmed.
The largest buyer was State Street, adding an estimated $14.8M. The largest seller was venBio Partners, exiting entirely with an estimated $8M sold.
- 118 institutional investors held Precision BioSciences (DTIL) as of Q4 2020, up from 116 in Q3 2020.
- Funds reported $231M of Precision BioSciences stock for Q4 2020, up 48% quarter-over-quarter.
- 18 funds opened new Precision BioSciences positions in Q4 2020 and 16 closed out, a net change of +2 holders.
- The largest Precision BioSciences buyer in Q4 2020 was State Street, an estimated $14.8M added.
- The largest Precision BioSciences seller in Q4 2020 was venBio Partners, an estimated $8M sold.
Based on aggregated 13F filings for Q4 2020.